DANIELLE WILLIAMS: Open Payments
NPI 1659956266 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 46 payments from 13 companies in 2025. Trend: 2023 $480 · 2024 $1,063 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $271 |
| AstraZeneca Pharmaceuticals LP | 9 | $200 |
| Baxter Healthcare | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Amgen Inc. | 2 | $41 |
| United Therapeutics Corporation | 1 | $32 |
| Verona Pharma, Inc. | 2 | $31 |
| Viatris Specialty LLC | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: NUCALA, TEZSPIRE, TRELEGY ELLIPTA, Hillrom - Monarch Airway Clearance System, DUPIXENT, GLASSIA, FASENRA, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
